Announcement • Jun 19
Grey Matters Health Inc. announced that it has received CAD 1.25 million in funding On June 18, 2026, Grey Matters Health Inc. closed the transaction. The company issued 1,875,000 units at an issue price of CAD 0.40 for gross proceeds of CAD 750,000 in its final tranche. The closing of the second tranche brings the financing to a total of CAD 1,250,000 from the sale of 3,125,000 units, including the closing of the first tranche. Certain insiders of the company participated in the second tranche of the offering in the amount of CAD 449,000. The company paid cash finder’s fees of CAD 28,000 and issued 70,000 finders warrants pertaining to the second tranche of the offering. The securities issued will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable Canadian securities legislation. New Risk • Apr 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 18% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (88% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.82m market cap, or US$1.34m). Minor Risk Share price has been volatile over the past 3 months (18% average weekly change). Announcement • Apr 23
Grey Matters Health Inc. announced that it expects to receive CAD 1 million in funding Grey Matters Health Inc. announced a non-brokered private placement to issue 2,500,000 units at an issue price of CAD 0.40 for the proceeds of CAD 1,000,000 on April 22, 2026. Each unit will consist of one Class A common share in the capital of the company and one common share purchase warrant. Each warrant will entitle the holder to acquire one common share at an exercise price of CAD 0.60 per warrant share for a period of 24 months from the issuance date. The offering is expected to close in tranches on or before May 21, 2026.The company may pay cash finders' fees and finder warrants to eligible finders, up to 8 per cent of the proceeds raised and units issued for investors introduced to the company by the eligible finders. Securities will be subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable Canadian securities legislation. 
